The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions

EuroIntervention 2013;9:721-729 published online ahead of print March 2013. DOI: 10.4244/EIJV9I6A116

1. Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil; 2. North Shore Hospital, Auckland, New Zealand; 3. Clinique Pasteur, Toulouse, France; 4. Harvard Clinical Research Institute, Boston, MA, USA; 5. Herzkatheterlabor und Pr

Aims: To assess the two-year clinical follow-up of the NEVO RES-1 study, a randomised comparison between the NEVO™ sirolimus-eluting cor

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Assessment of self-expanding nitinol stent deformation after chronic implantation into the femoropopliteal arteries